25.71 USD
▲0.00+2.84%
盘后 25.10 +0.40%
2026-08-03
市值
$1.02B
市盈率
3.77
EPS
-6.28
股息率
—
52 周区间
16.12 – 29.15
成交量
298.43K
Beta
—
目标价
—
52W 低 16.1252W 高 29.15
价格走势
公司简介
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.